Variant position: 201 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 919 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LSIDESSLTGETTPCSKVTA PQPAATNGDLASRSNIAFMGT
Mouse LSVDESSLTGETAPCSKVTA PQPAA-NGDLASRSNIAFMGT
Rat LSIDESSLTGETTPCSKVTA PQPAATNGDLASRSNIAFMGT
Bovine LSVDESSLTGETTPCSKVTA PQPAATNGDLASRSNIAFMGT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 919 Calcium-transporting ATPase type 2C member 1
124 – 262 Cytoplasmic
Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump.
Sudbrak R.; Brown J.; Dobson-Stone C.; Carter S.; Ramser J.; White J.; Healy E.; Dissanayake M.; Larregue M.; Perrussel M.; Lehrach H.; Munro C.S.; Strachan T.; Burge S.; Hovnanian A.; Monaco A.P.;
Hum. Mol. Genet. 9:1131-1140(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4); VARIANTS HHD LEU-201; TYR-344 AND ILE-570;
Effect of Hailey-Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1).
Fairclough R.J.; Dode L.; Vanoevelen J.; Andersen J.P.; Missiaen L.; Raeymaekers L.; Wuytack F.; Hovnanian A.;
J. Biol. Chem. 278:24721-24730(2003)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 9); FUNCTION; SUBCELLULAR LOCATION; CATALYTIC ACTIVITY; CHARACTERIZATION OF VARIANTS HHD LEU-201; CYS-309; PRO-341; TYR-344; ARG-411; ILE-570; VAL-580; TYR-742 AND ARG-789;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.